ELDN
NASDAQ · Biotechnology
Eledon Pharmaceuticals Inc
$3.94
+0.06 (+1.55%)
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+206.9% upside
Low Target
$9.42
Average Target
$12.09
High Target
$15.53
Current Price
$3.94
Current
$3.94
$3.94
Target
$12.09
$12.09
$9.42
$12.09 avg
$15.53
Scenario Analysis
Bear Case
$9.42
139.1%
Low target
Base Case
$12.09
+206.9%
Avg target
Bull Case
$15.53
+294.2%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$4.60
-14.3% from high
52-Week Low
$1.35
+191.9% from low
Target vs 52W High
$12.09
+162.8% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 40 | 78% | $257.58 | +2.4% |
| AMGN | Hold | 44 | 50% | $190.87 | -47.3% |
| GILD | Strong Buy | 39 | 82% | $362.68 | +187.1% |
| VRTX | Strong Buy | 40 | 83% | $438.34 | -11.8% |
| REGN | Buy | 38 | 71% | $76.80 | -87.7% |
| ALNY | Strong Buy | 37 | 76% | $102.31 | -66.0% |
| RVMD | Strong Buy | 27 | 96% | $114.11 | -39.1% |
| NTRA | Strong Buy | 27 | 89% | $142.91 | -47.4% |